2018 to 2021 Saw Increase in HIV PrEP Provision for Adolescents
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Oct. 30, 2023 -- From 2018 to 2021, there was an increase in HIV preexposure prophylaxis (PrEP) provision among adolescents, especially among male and older adolescents, according to a study published online Oct. 30 in Pediatrics.
Anne A. Kimball, M.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined trends in adolescents prescribed PrEP during 2018 through 2021. In addition, the characteristics of adolescents and their PrEP providers were examined.
The researchers found that despite decreases in 2020, there was a 76.2 percent increase in the number of adolescents prescribed PrEP from 2018 to 2021 (estimated annual percentage change, 18.0 percent). Increases were seen in all sex and age groups, with larger increases among older adolescents aged 18 to 19 years. Of the 6,444 adolescents prescribed PrEP in 2021, 82.6 and 87.8 percent were male and were aged 18 to 19 years, respectively. Overall, 29.6 percent of the 2,455 physician PrEP providers were pediatricians, with varying specialty distributions seen by adolescent age group. Two-thirds (67.7 percent) of the 217 pediatricians who prescribed PrEP to adolescents aged 13 to 17 years were general pediatricians.
"Increases in the number of adolescents prescribed PrEP are encouraging, but also highlight opportunities for improvement," the authors write. "Our findings can provide a baseline for monitoring future trends toward wider and more equitable PrEP provision."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Recommended Treatment for STIs More Likely in Public Versus Private Health Care Settings
TUESDAY, April 30, 2024 -- Individuals seen for sexually transmitted infections (STIs) by clinicians in a private U.S. health care setting are less likely to receive recommended...
Cognitive Impairment Still Seen in Children, Teens With HIV
TUESDAY, April 30, 2024 -- Cognitive impairment persists in children and adolescents living with HIV even in the era of antiretroviral therapy (ART), according to research...
Pandemic Reignited Debate Regarding Physician's Obligation to Treat
MONDAY, April 29, 2024 -- There was a surge in ethics literature during COVID-19 advocating for the ethical acceptability of physicians refusing to treat, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.